OLN
Olin Corporation
Basic Materials · Chemicals - Specialty
Undervalued·Quality 50·RSI 60·DCF +115%·Conviction 70
Investment Thesis — Olin Corporation
The market is overreacting to Olin's recent earnings miss and negative EPS, extrapolating a cyclical trough as a structural decline. This mispricing ignores Olin's ability to rapidly cut costs and reprice contracts in a tightening chemical market, setting up for sharp operating leverage on even modest demand recovery.
Catalysts
- Chemical price recovery driven by supply cuts
- Aggressive share repurchases resuming
- Strategic asset sale or industry consolidation
Risk Factors
- Prolonged global demand weakness
- Loss of pricing power to larger competitors
- Debt covenant breach triggering forced asset sales
Key Debates
OLN will either short squeeze above $30 or revert to $22.40 by Q4.
Olin's Fwd Rev Growth turns positive by Q3, re-rating the stock.
Recent 21.77% rally is sustainable, pushing RSI above 70 by Q4.